Cargando…

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus

As a high-risk factor of perinatal HBV transmission, the potential role of maternal hepatitis B e antigen (HBeAg) to guide antiviral prophylaxis has not yet been fully reported. This large prospective cohort study enrolled 1177 hepatitis B surface antigen (HBsAg)-positive pregnant women without anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Ying, Song, Yarong, Zhai, Xiangjun, Zhu, Fengcai, Liu, Jianxun, Chang, Zhanjun, Li, Yi, Xiao, Yiwei, Li, Lili, Liu, Minmin, Liu, Jia, Duan, Zhongping, Zou, Huaibin, Zhuang, Hui, Wang, Jie, Li, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018376/ https://www.ncbi.nlm.nih.gov/pubmed/33682609 http://dx.doi.org/10.1080/22221751.2021.1899055

Ejemplares similares

A booster hepatitis B vaccine for children with maternal HBsAg positivity before 2 years of age could effectively prevent vaccine breakthrough infections
por: Song, Yarong, et al.
Publicado: (2022)

Reduction of the occurrence of occult HBV infection in infants by increasing the dose of hepatitis B vaccine: a large prospective cohort study
por: Li, Yi, et al.
Publicado: (2020)

Quasispecies characteristic in “a” determinant region is a potential predictor for the risk of immunoprophylaxis failure of mother-to-child-transmission of sub-genotype C2 hepatitis B virus: a prospective nested case–control study
por: Xiao, Yiwei, et al.
Publicado: (2020)

Booster Vaccination in Infancy Reduces the Incidence of Occult HBV Infection in Maternal HBsAg-positive Children
por: Li, Yi, et al.
Publicado: (2023)

The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study
por: Li, Yi, et al.
Publicado: (2021)

Vaginal Delivery and Breastfeeding Benefit Infant Immune Response to Hepatitis B Vaccine: A Prospective Cohort Study
por: Liu, Huiqing, et al.
Publicado: (2023)

Antiviral Therapy for Prevention of Perinatal Hepatitis B Virus Transmission Reduces the Incidence of Postpartum Hepatitis Flare
por: Quan, Min, et al.
Publicado: (2022)

Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea
por: Lee, Donghoon, et al.
Publicado: (2018)

Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother‐to‐child transmission of hepatitis B virus
por: Zhao, Mengyu, et al.
Publicado: (2019)

Protective Effect of Hepatitis B Vaccine Combined with Two-Dose Hepatitis B Immunoglobulin on Infants Born to HBsAg-Positive Mothers
por: Zou, Huaibin, et al.
Publicado: (2011)

Risk factors related to postpartum hepatic inflammation in pregnant women with chronic hepatitis B
por: Li, Lu, et al.
Publicado: (2020)

Expanding Antiviral Prophylaxis During Pregnancy to Prevent Perinatal Hepatitis B Virus Infection: A Cost-effectiveness Study
por: Du, Jiangyang, et al.
Publicado: (2020)

Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus
por: Wang, Wenjun, et al.
Publicado: (2016)

Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus
por: Pan, Xingfei, et al.
Publicado: (2020)

The effects of increased dose of hepatitis B vaccine on mother-to-child transmission and immune response for infants born to mothers with chronic hepatitis B infection: a prospective, multicenter, large-sample cohort study
por: Zhang, Xiaohui, et al.
Publicado: (2021)

Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis
por: Wu, Yu-tuan, et al.
Publicado: (2017)

Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers
por: Zhang, Wenjun, et al.
Publicado: (2022)

Incidence of mother‐to‐child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta‐analysis
por: Yao, Naijuan, et al.
Publicado: (2022)

Willing to Pay for Antiviral Treatment of Hepatitis B Patients
por: ZHANG, Hua, et al.
Publicado: (2016)

Host Genetic Determinants of Hepatitis B Virus Infection
por: Zhang, Zhenhua, et al.
Publicado: (2019)

Antiviral treatment for chronic hepatitis B: Safety, effectiveness, and prognosis
por: Wu, Ya-Li, et al.
Publicado: (2019)

Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
por: Xu, Kerui, et al.
Publicado: (2018)

Identification of pro-inflammatory CD205(+) macrophages in livers of hepatitis B virus transgenic mice and patients with chronic hepatitis B
por: Yong, Liang, et al.
Publicado: (2017)

Distribution of hepatitis B virus genotypes and subgenotypes: A meta-analysis
por: Liu, Zhongping, et al.
Publicado: (2021)

Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them
por: Seo, Kwang Il, et al.
Publicado: (2018)

Safety of entecavir antiviral therapyduring an accidental pregnancy in patients with chronic hepatitis B
por: Cao, Lihua, et al.
Publicado: (2023)

Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
por: Hou, Jinlin, et al.
Publicado: (2017)

Hepatitis B sero-prevalence among hematology patients: importance of Anti-HbcAb and efficiency of antiviral prophylaxis
por: Kantar, Funda Ugur, et al.
Publicado: (2022)

Risk of perinatal transmission of hepatitis B virus in Jordan.
por: Batayneh, Naji, et al.
Publicado: (2002)

Novel insights in the prevention of perinatal transmission of hepatitis B
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

The Impact of Vaccination and Antiviral Therapy on Hepatitis B and Hepatitis D Epidemiology
por: Goyal, Ashish, et al.
Publicado: (2014)

Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004)

Antiviral treatment in severe acute hepatitis B
por: Streinu-Cercel, Anca, et al.
Publicado: (2014)

Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014)

Management of Antiviral Resistance in Chronic Hepatitis B
por: Lim, Young-Suk
Publicado: (2017)

Advances in new antivirals for chronic hepatitis B
por: Tang, Yanhua, et al.
Publicado: (2022)

Circulating and intrahepatic antiviral B cells are defective in hepatitis B
por: Burton, Alice R., et al.
Publicado: (2018)

Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism
por: Liang, Huiqing, et al.
Publicado: (2020)

Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection
por: Chae, Hee Bok, et al.
Publicado: (2007)

Quantifying perinatal transmission of Hepatitis B viral quasispecies by tag linkage deep sequencing
por: Du, Yushen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s6r7v0rb337l6d4dk762335e0a